Most of the studies have shown a strong and independent association between FGF-23 concentrations and greater risk of end-stage renal disease in advanced-stage CKD patients [32,33], thereby making it an independent risk factor for mortality in this population [32,34]. This evidence concerns the gene FGF23 and chronic kidney disease.